Aspergillus tubingensis: A Rare Fungal Pathogen Complicating COVID-19 Case

Area of Science:

• Mycology
• Infectious Diseases
• Critical Care Medicine

Background:

• Coronavirus disease 2019 (COVID-19) is increasingly associated with invasive fungal infections.
• Coinfections with Aspergillus, Rhizopus, and Mucor species have been reported in COVID-19 patients.
• This report details a unique case of COVID-19 with Aspergillus tubingensis coinfection.

Purpose of the Study:

• To present a case of coinfection between COVID-19 and Aspergillus tubingensis.
• To emphasize the importance of accurate species-level identification of fungal pathogens.
• To highlight the challenges in diagnosing and treating invasive fungal infections in the context of COVID-19.

Main Methods:

• A case presentation of a male patient with severe COVID-19 pneumonia.
• Inclusion of patient's comorbidities (diabetes, hypertension) and clinical course.
• Postmortem molecular identification using ITS sequencing for fungal pathogen confirmation.

Main Results:

• The patient presented with severe symptoms including fever, cough, shortness of breath, and abdominal pain.
• Complications included sepsis, hospital-acquired pneumonia, septic shock, acute kidney injury, and disseminated intravascular coagulation.
• Postmortem analysis confirmed Aspergillus tubingensis as the causative fungal agent.

Conclusions:

• Invasive fungal infections carry a high mortality rate.
• Prompt and accurate species-level diagnosis is essential for effective treatment strategies.
• This case underscores the need for vigilance regarding fungal coinfections in severe COVID-19 cases.